Axially Chiral Compounds 2021
DOI: 10.1002/9783527825172.ch5
|View full text |Cite
|
Sign up to set email alerts
|

Asymmetric Synthesis of Nonbiaryl Atropisomers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 96 publications
0
1
0
Order By: Relevance
“…While traditional resolution methods can furnish enantiopure samples from racemic mixtures, they can often be time-consuming, resource-intensive, and not practical in the context of structure optimization. These challenges have been given a recent spotlight as more class-3 atropisomers make it to the clinic, often requiring heroic efforts to meet the challenges of material throughput. , While atroposelective methods have been studied for decades, they have largely focused on biaryls, leaving relatively few methodologies , that are applicable to the other pharmaceutically relevant scaffolds. This has led our group to embark on a series of projects that focus on the development of atropisomer-selective methodologies toward pharmaceutically relevant scaffolds.…”
Section: Atropisomer Selective Synthesis Of Pharmaceutically Relevant...mentioning
confidence: 99%
“…While traditional resolution methods can furnish enantiopure samples from racemic mixtures, they can often be time-consuming, resource-intensive, and not practical in the context of structure optimization. These challenges have been given a recent spotlight as more class-3 atropisomers make it to the clinic, often requiring heroic efforts to meet the challenges of material throughput. , While atroposelective methods have been studied for decades, they have largely focused on biaryls, leaving relatively few methodologies , that are applicable to the other pharmaceutically relevant scaffolds. This has led our group to embark on a series of projects that focus on the development of atropisomer-selective methodologies toward pharmaceutically relevant scaffolds.…”
Section: Atropisomer Selective Synthesis Of Pharmaceutically Relevant...mentioning
confidence: 99%